Bianco Research President Jim Bianco discusses how to position your portfolio for the New Year.
FBN’s Charles Payne, Penn Financial Group Founder and President Mathew McCall, Capitalistpig.com Founder Jonathan Hoenig, author Hitha Prabhakar and Monster Worldwide Senior Vice President Joanie Courtney discuss retirement planning as life expectancy for Americans increases.
Fox News Medical A-Team's Dr. Marc Siegel discusses a new drug to treat breast cancer.
FBN’s Liz MacDonald on deal stocks under pressure as the U.S. announces stricter tax rules.
Holland & Company chairman Mike Holland, United Advisors chief market strategist Scott Martin, and Hedgeye CEO Keith McCullough give their outlook for social media stocks.
RJ O’Brien director John Brady and WSJ mergers and acquisitions reporter Dana Mattioli on Warren Buffet’s move to back Burger King’s merger with Tim Hortons.
FBN’s Liz MacDonald on big name companies in correction mode.
Wells Fargo senior economist Mark Vitner gives insight into the July jobs report.
FBN’s Maria Bartiromo breaks down what you need to know in business news today.
Earnings HQ: FBN’s Lori Rothman breaks down Pfizer ’s second-quarter earnings report.
Eli Lilly CEO John Lechleiter discusses 2Q earnings and the impact of recent patent expirations.
Johnson & Johnson CEO Alex Gorsky discusses companies moving business out of the U.S. because of taxes and ObamaCare’s impact.
Rich Jeanneret of E&Y Transaction Adivsor Americas, Jones Day Global M&A chairman Bob Profusek and Hedgeye Risk Management CEO Keith McCullough give their outlook for M&A deals.
Mendon Capital Advisors President Anton Schutz and BNP Paribas Head of Equity Cash Trading Darren Wolfberg discuss how weak economic data in Europe impact investment strategies in the U.S. and their outlook for the markets.
S&P Capital IQ Senior Director Rich Peterson, Veracruz Founder Steve Cortes and Morgan Creek Capital Management CEO Mark Yusko discuss how to prepare your portfolio for 2015.
FBN’s Ashley Webster breaks down the details of Pfizer ’s cancer drug deal with Merck.
David Benoit and Liz Hoffman of The Wall Street Journal on activist investor Bill Ackman’s new stake in animal health company Zoetis.
Consumer Advocate Ralph Nader argues the least productive thing Apple’s Tim Cook could do is buy back stock.
Earnings HQ: FBN’s Lori Rothman breaks down Pfizer ’s third-quarter earnings report.
Point View Wealth Management President David Dietze and Janney Montgomery Scott Chief Investment Strategist Mark Luschini discuss their outlooks for the markets.